vs
Side-by-side financial comparison of LXP Industrial Trust (LXP) and STEM, INC. (STEM). Click either name above to swap in a different company.
LXP Industrial Trust is the larger business by last-quarter revenue ($86.7M vs $47.1M, roughly 1.8× STEM, INC.). LXP Industrial Trust runs the higher net margin — 33.2% vs -33.9%, a 67.1% gap on every dollar of revenue. On growth, LXP Industrial Trust posted the faster year-over-year revenue change (-14.0% vs -15.6%). Over the past eight quarters, STEM, INC.'s revenue compounded faster (36.1% CAGR vs 0.3%).
LXP Industrial Trust is a publicly traded real estate investment trust (REIT) that owns, operates, and invests in high-quality industrial real estate assets, primarily distribution centers, logistics facilities, and light industrial properties across key markets in the United States. Its tenant base covers e-commerce, third-party logistics, and advanced manufacturing sectors, delivering stable long-term returns for its investors.
StemCells, Inc. is a public biopharmaceutical company headquartered in Newark, California, that is developing purified human neural stem cells (HuCNS-SCs) in the hopes of treating central nervous system disorders and paralysis. StemCells' HuCNS-SCs have the ability to differentiate into the three main types of cells found in the central nervous system: neurons, astrocytes and oligodendrocytes.
LXP vs STEM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $86.7M | $47.1M |
| Net Profit | $28.8M | $-16.0M |
| Gross Margin | 81.5% | 48.9% |
| Operating Margin | 34.6% | -17.7% |
| Net Margin | 33.2% | -33.9% |
| Revenue YoY | -14.0% | -15.6% |
| Net Profit YoY | — | 68.8% |
| EPS (diluted) | — | $-4.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $86.7M | $47.1M | ||
| Q3 25 | $86.9M | $38.2M | ||
| Q2 25 | $87.7M | $38.4M | ||
| Q1 25 | $88.9M | $32.5M | ||
| Q4 24 | $100.9M | $55.8M | ||
| Q3 24 | $85.6M | $29.3M | ||
| Q2 24 | $85.8M | $34.0M | ||
| Q1 24 | $86.3M | $25.5M |
| Q4 25 | $28.8M | $-16.0M | ||
| Q3 25 | $36.3M | $-23.8M | ||
| Q2 25 | $29.1M | $202.5M | ||
| Q1 25 | $19.0M | $-25.0M | ||
| Q4 24 | — | $-51.1M | ||
| Q3 24 | $6.3M | $-148.3M | ||
| Q2 24 | $5.4M | $-582.3M | ||
| Q1 24 | $-269.0K | $-72.3M |
| Q4 25 | 81.5% | 48.9% | ||
| Q3 25 | 82.3% | 35.5% | ||
| Q2 25 | 81.9% | 33.4% | ||
| Q1 25 | 80.7% | 32.4% | ||
| Q4 24 | 85.3% | -4.4% | ||
| Q3 24 | 82.5% | 21.2% | ||
| Q2 24 | 82.0% | 27.6% | ||
| Q1 24 | 82.4% | -95.0% |
| Q4 25 | 34.6% | -17.7% | ||
| Q3 25 | 50.4% | -33.6% | ||
| Q2 25 | 33.7% | -34.8% | ||
| Q1 25 | 21.8% | -65.0% | ||
| Q4 24 | — | -84.4% | ||
| Q3 24 | 7.9% | -493.2% | ||
| Q2 24 | 6.9% | -1705.5% | ||
| Q1 24 | 1.0% | -267.0% |
| Q4 25 | 33.2% | -33.9% | ||
| Q3 25 | 41.7% | -62.2% | ||
| Q2 25 | 33.2% | 527.8% | ||
| Q1 25 | 21.4% | -76.9% | ||
| Q4 24 | — | -91.6% | ||
| Q3 24 | 7.4% | -506.3% | ||
| Q2 24 | 6.3% | -1712.6% | ||
| Q1 24 | -0.3% | -283.9% |
| Q4 25 | — | $-4.40 | ||
| Q3 25 | $0.12 | $-2.84 | ||
| Q2 25 | $0.09 | $-1.79 | ||
| Q1 25 | $0.06 | $-0.15 | ||
| Q4 24 | — | $-15.29 | ||
| Q3 24 | $0.02 | $-18.24 | ||
| Q2 24 | $0.01 | $-71.81 | ||
| Q1 24 | $-0.01 | $-0.46 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $170.4M | $48.9M |
| Total DebtLower is stronger | $1.4B | — |
| Stockholders' EquityBook value | $2.0B | $-249.4M |
| Total Assets | $3.5B | $308.9M |
| Debt / EquityLower = less leverage | 0.66× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $170.4M | $48.9M | ||
| Q3 25 | $229.7M | $43.1M | ||
| Q2 25 | $71.0M | $40.8M | ||
| Q1 25 | $70.9M | $58.6M | ||
| Q4 24 | $101.8M | $56.3M | ||
| Q3 24 | $55.0M | $75.4M | ||
| Q2 24 | $48.7M | $89.6M | ||
| Q1 24 | $293.8M | $112.8M |
| Q4 25 | $1.4B | — | ||
| Q3 25 | $1.5B | — | ||
| Q2 25 | $1.5B | — | ||
| Q1 25 | $1.5B | — | ||
| Q4 24 | $1.6B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $2.0B | $-249.4M | ||
| Q3 25 | $2.1B | $-235.7M | ||
| Q2 25 | $2.1B | $-214.1M | ||
| Q1 25 | $2.1B | $-417.5M | ||
| Q4 24 | $2.1B | $-398.4M | ||
| Q3 24 | $2.1B | $-344.1M | ||
| Q2 24 | $2.1B | $-203.2M | ||
| Q1 24 | $2.2B | $371.6M |
| Q4 25 | $3.5B | $308.9M | ||
| Q3 25 | $3.7B | $362.6M | ||
| Q2 25 | $3.7B | $379.2M | ||
| Q1 25 | $3.8B | $405.1M | ||
| Q4 24 | $3.8B | $437.4M | ||
| Q3 24 | $3.9B | $537.8M | ||
| Q2 24 | $3.9B | $691.5M | ||
| Q1 24 | $4.2B | $1.3B |
| Q4 25 | 0.66× | — | ||
| Q3 25 | 0.72× | — | ||
| Q2 25 | 0.72× | — | ||
| Q1 25 | 0.73× | — | ||
| Q4 24 | 0.75× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $188.7M | $8.2M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 6.56× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $188.7M | $8.2M | ||
| Q3 25 | $63.5M | $11.4M | ||
| Q2 25 | $44.3M | $-21.3M | ||
| Q1 25 | $39.0M | $8.5M | ||
| Q4 24 | $211.2M | $-14.7M | ||
| Q3 24 | $64.6M | $-9.4M | ||
| Q2 24 | $38.5M | $-11.9M | ||
| Q1 24 | $38.9M | $-621.0K |
| Q4 25 | 6.56× | — | ||
| Q3 25 | 1.75× | — | ||
| Q2 25 | 1.52× | -0.11× | ||
| Q1 25 | 2.05× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 10.18× | — | ||
| Q2 24 | 7.09× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
